CompuMed, Inc. (CMPD.OB)
()
 
 

Overview

CompuMed, Inc. develops and markets products and services that use advanced imaging and medical informatics to provide analysis and remote monitoring in connection with cardiovascular and musculoskeletal diseases. CompuMed has specialized expertise and intellectual properties in telemonitoring imaging and analysis designed to improve healthcare provider workflow and patient care, while reducing costs. CompuMed's core products, the OsteoGramĀ® and CardioGram(TM), are cleared by the FDA and reimbursable by Medicare. The OsteoGram is a non-invasive and simple diagnostic system that has been proven by many clinical studies to be an effective and accurate bone density measurement in connection with screening for osteoporosis and assessing hip fracture risk. The OsteoGram has significant cost advantages over other technologies in the marketplace. The CardioGram system is one of the first telecommunication networks designed to remotely interpret electrocardiograms and is used by private practice, ...


Contact Information

5777 West Century Boulevard
Suite1285
Los Angeles, CA 90045

tel: 310-258-5000
fax: 310-645-5880
http://www.compumed.net

,  



Investor Relations



tel:
fax:




Stock

Exchange: OTCBB
Industry: Healthcare Information Services
Market Cap: $7.4M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.